Cargando…

Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights

Detalles Bibliográficos
Autores principales:	Honore, Patrick M., Mugisha, Aude, Barreto Gutierrez, Leonel, Redant, Sebastien, Kaefer, Keitiane, Gallerani, Andrea, De Bels, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907280/ https://www.ncbi.nlm.nih.gov/pubmed/31831032 http://dx.doi.org/10.1186/s13054-019-2692-2

Ejemplares similares

Comparison between meropenem and ceftolozane/tazobactam: possible influence of CRRT
por: Honore, Patrick M., et al.
Publicado: (2022)

Interleukin-26 is a promising biomarker of sepsis but is it always reliable?
por: Honore, Patrick M., et al.
Publicado: (2019)

Dysbiosis of the microbiota in neurocritically ill patients associated with coma and death: ammonia as a potential missing link
por: Honore, Patrick M., et al.
Publicado: (2019)

Biomarker suPAR seems a good prognostic factor for community-acquired pneumonia but less prominent for septic shock
por: Honore, Patrick M., et al.
Publicado: (2019)

How levosimendan can improve renal function?
por: Honore, Patrick M., et al.
Publicado: (2019)

Obesity inducing acute respiratory distress syndrome: we should choose the right population!
por: Honore, Patrick M., et al.
Publicado: (2019)

What should be the best dialysis catheter lock in critically ill patients?
por: Honore, Patrick M., et al.
Publicado: (2019)

High levels of plasma biomarkers at 24 h were found to be strong predictors of 90-day mortality: beware of some potential confounders!
por: Honore, Patrick M., et al.
Publicado: (2021)

A Study Revealed That a High Percentage of Patients With Severe COVID-19 With Viral RNAaemia Had Significantly Worse Outcomes, and This Is the First Report About the Risk Factors of Viral RNAaemia in Patients With COVID-19: We Are Not Sure!
por: Honore, Patrick M., et al.
Publicado: (2021)

Spontaneous Pneumothorax (SP) in COVID-19 Is Associated With Worse Outcomes Than SP in Non-COVID-19 Patients, Which Suggests That SP in COVID-19 is a Sign of Disease Severity: Is This Finding a Pure Association or Is There Really a Strong Relationship Between the Two?
por: Honore, Patrick M., et al.
Publicado: (2021)

Are SOFA score, PaO(2)/FiO(2) ratio, lymphocytes levels, total bilirubin, lactate dehydrogenase, ferritin, C-reactive protein and interleukin-6 significantly normalized following TPE completion: Is this fact or fiction?
por: Honore, Patrick M., et al.
Publicado: (2021)

MR-proADM has a good ability to predict 28-day mortality in critically ill patients with SARS-CoV-2 pneumonia: Beware of some potential confounders!
por: Honore, Patrick M., et al.
Publicado: (2022)

Study conclude that routinely monitoring of sputum viral load in severe COVID-19 patients may be beneficial for development of infection control guidelines and prediction of prognosis: We are not sure!
por: Honore, Patrick M., et al.
Publicado: (2022)

Indirect calorimetry is the gold standard to assess REE in ICU patients: some limitations to consider
por: Honore, Patrick M., et al.
Publicado: (2021)

Study find that COVID ARDS was associated with a low risk for possible or proven PCP: still true after dexamethasone use
por: Honore, Patrick M., et al.
Publicado: (2022)

Success rate of naso-jejunal tube placement influenced by CRRT: possible removal of metoclopramide
por: Honore, Patrick M., et al.
Publicado: (2021)

Higher incidence of arrhythmia in COVID-19 than in other community-acquired pneumonia: possible role of concurrent therapies
por: Honore, Patrick M., et al.
Publicado: (2021)

Study conclude that TXA in severely injured was associated with lower mortality: beware of potential confounders
por: Honore, Patrick M., et al.
Publicado: (2021)

Who may benefit most from future vitamin D intervention trials: do not forget patients on continuous renal replacement therapy
por: Honore, Patrick M., et al.
Publicado: (2020)

Anisodamine microcirulatory effects in septic shock: be aware of cardiac side effects
por: Honore, Patrick M., et al.
Publicado: (2021)

Is endocan correlated to ARDS severity or an epiphenomenon of thrombo-embolic disease in COVID
por: Honore, Patrick M., et al.
Publicado: (2021)

Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances
por: Aguilar, Gerardo, et al.
Publicado: (2020)

Membrane adsorption in vancomycin treatment is membrane type dependent in CVVHDF: dose correction is crucial
por: Honore, Patrick M., et al.
Publicado: (2022)

Austrian recommendations for best clinical practice in case of haemorrhagic traumatic brain injury under platelet inhibitors or non-vitamin K antagonist oral anticoagulants: an additional therapeutic option to consider
por: Honore, Patrick M., et al.
Publicado: (2020)

Difference of 11 years between two periods of VV-ECMO does not impact mortality in large centres: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2022)

Adsorption and caspofungin dosing during continuous renal replacement therapy
por: Honore, Patrick M., et al.
Publicado: (2019)

Optimizing ceftolozane-tazobactam dosage in critically ill patients during continuous venovenous hemodiafiltration
por: Aguilar, Gerardo, et al.
Publicado: (2019)

Endocan removal during continuous renal replacement therapy: does it affect the reliability of this biomarker?
por: Honore, Patrick M., et al.
Publicado: (2019)

Icatibant, another piece of the therapeutic puzzle regarding hemodynamic side effects of angiotensin-converting enzyme inhibitors
por: Honore, Patrick M., et al.
Publicado: (2019)

Endotoxin removal by polymyxin B: is it a question of dose or duration or both?
por: Honore, Patrick M., et al.
Publicado: (2019)

Sevoflurane and nephrogenic diabetes insipidus on the rise: copeptin to the rescue?
por: Honore, Patrick M., et al.
Publicado: (2019)

Treatment of influenza virus-related critical illness during continuous renal replacement therapy: take caution with dosing
por: Honore, Patrick M., et al.
Publicado: (2020)

No dose adjustment of tigecycline is necessary during continuous renal replacement therapy: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2020)

Endarterectomy treatment for patients suffering from a new episode of pulmonary embolism, after screening for chronic thromboembolic pulmonary hypertension
por: Honore, Patrick M., et al.
Publicado: (2022)

Vitamin C Dosing During Continuous Renal Replacement Therapy: The Last Word is Not Said!
por: Honore, Patrick M., et al.
Publicado: (2019)

High doses of ketamine to improve neuronal edema in subarachnoid hemorrhage: we should consider other undesirable organ targets
por: Honore, Patrick M., et al.
Publicado: (2020)

With the current COVID pandemic: should we use single-use flexible bronchoscopes instead of conventional bronchoscopes?
por: Honore, Patrick M., et al.
Publicado: (2020)

The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients: is moderate ARDS the best indication for neuromuscular blocking agents
por: Honore, Patrick M., et al.
Publicado: (2020)

Therapeutic plasma exchange as a routine therapy in septic shock and as an experimental treatment for COVID-19: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2020)

N-terminal pro-brain natriuretic peptide levels during the acute phase of sepsis may be a useful indicator of higher risk of long-term impairments: some confounders to consider
por: Honore, Patrick M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h0mapdqr1svmkt9e9nrs4t9a0k